Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Standard message
Total 0 results
Nothing found
Sponsors and Collaborators
Hungarian Dental Association
Université de Genève (UNIGE)
Cogniciti
Shanghai GeneChem Co., Ltd.
Defence Services Medical Academy (DSMA), Myanmar
The Affiliated Hospital of Xuzhou Medical University
Huisartspraktijk Handellaan
Smart Meter Corporation
NERv Technology Inc
Vivid Pharma Inc.
BioNova Pharmaceuticals (Shanghai) LTD.
Impulse Dynamics, Inc.
UNITI Consortium
Nutrabolt
HBSA
Salena Killion
Zhongda Hospital, Medical School, Southeast University
Pia Jaeger, MD, PhD
Health Information Technology Solutions (HITS) LLC
Ministry of Public Health, Cameroon
View Full List
Medical Conditions
SMA - Spinal Muscular Atrophy
Biomarkers, Pharmacological
Vertebral Compression Fractures in Osteoporotic Patients
Failed Induction
Old Age (Focus; Not a Recognized Condition)
Endoleaks
Premature Rupture of Membranes Prolonged
Pain, Breakthrough
Cerebral Arterial Disease
VEXAS Syndrome
PPA Syndrome
Advanced Bladder Carcinoma
Alzheimer Disease Focal
PET-CT Specimen Imager
Immediate Implant Placement
Research Mentoring Skills
Radiofrequency Ablation Treatment
Cardiovascular Primary Prevention
Infection, Bacterial
Eye Disease, Hereditary
View Full List
Drug Interventions
CJ-12420 200mg + Clarithromycin 500mg
Lacosamide
0.75% Ropivacaine
HPN328
18F-FDG
Rosuvastatin
Acetylsalicylic acid
5 FU continuous
TQB2450
OXP005
Oxymorphone hydrochloride (HCl)
20 mg/kg IV FL-301
Cefadroxil until drain removal
CNTO 6785 50 mg
INT-747
Olopatadine hydrochloride 0.2%
80% oxygen
Microneedling with topical glycolic acid 35%.
Durvalumab + chemotherapy treatment
Phase B: Triplixam / Elestar HCT
View Full List
CROs by country
Contract Research Organizations in Belarus
Contract Research Organizations in Burundi
Contract Research Organizations in Colombia
Contract Research Organizations in Cote d'Ivoire
Contract Research Organizations in Gambia
Contract Research Organizations in Germany
Contract Research Organizations in Guinea
Contract Research Organizations in Japan
Contract Research Organizations in Malawi
Contract Research Organizations in Panama
Contract Research Organizations in Rwanda
Contract Research Organizations in South Africa
Contract Research Organizations in Tanzania
CRO list by country
CROs in Malaysia
Novotech
ICON
Syneos Health
Info Kinetics Sdn Bhd
Fortrea
Celero
Caidya
SGS
ACROSS Global
ClinActis
All CROs in Malaysia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe